Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation.
Entezari M, Hashemi D, Taheriazam A, Zabolian A, Mohammadi S, Fakhri F, Hashemi M, Hushmandi K, Ashrafizadeh M, Zarrabi A, Ertas YN, Mirzaei S, Samarghandian S. Entezari M, et al. Among authors: ertas yn. Biomed Pharmacother. 2022 Feb;146:112563. doi: 10.1016/j.biopha.2021.112563. Epub 2021 Dec 29. Biomed Pharmacother. 2022. PMID: 35062059 Free article. Review.
Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidence.
Paskeh MDA, Mirzaei S, Orouei S, Zabolian A, Saleki H, Azami N, Hushmandi K, Baradaran B, Hashmi M, Aref AR, Ertas YN, Zarrabi A, Ashrafizadeh M, Samarghandian S. Paskeh MDA, et al. Among authors: ertas yn. Int J Biol Macromol. 2021 Nov 30;191:727-737. doi: 10.1016/j.ijbiomac.2021.09.089. Epub 2021 Sep 22. Int J Biol Macromol. 2021. PMID: 34562537 Review.
Gene regulation by antisense transcription: A focus on neurological and cancer diseases.
Najafi S, Tan SC, Raee P, Rahmati Y, Asemani Y, Lee EHC, Hushmandi K, Zarrabi A, Aref AR, Ashrafizadeh M, Kumar AP, Ertas YN, Ghani S, Aghamiri S. Najafi S, et al. Among authors: ertas yn. Biomed Pharmacother. 2022 Jan;145:112265. doi: 10.1016/j.biopha.2021.112265. Epub 2021 Nov 8. Biomed Pharmacother. 2022. PMID: 34749054 Free article. Review.
EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects.
Paskeh MDA, Mehrabi A, Gholami MH, Zabolian A, Ranjbar E, Saleki H, Ranjbar A, Hashemi M, Ertas YN, Hushmandi K, Mirzaei S, Ashrafizadeh M, Zarrabi A, Samarghandian S. Paskeh MDA, et al. Among authors: ertas yn. Biomed Pharmacother. 2022 Feb;146:112532. doi: 10.1016/j.biopha.2021.112532. Epub 2021 Dec 11. Biomed Pharmacother. 2022. PMID: 34906772 Free article. Review.
Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance.
Hashemi M, Hajimazdarany S, Mohan CD, Mohammadi M, Rezaei S, Olyaee Y, Goldoost Y, Ghorbani A, Mirmazloomi SR, Gholinia N, Kakavand A, Salimimoghadam S, Ertas YN, Rangappa KS, Taheriazam A, Entezari M. Hashemi M, et al. Among authors: ertas yn. Pharmacol Res. 2022 Dec;186:106535. doi: 10.1016/j.phrs.2022.106535. Epub 2022 Nov 2. Pharmacol Res. 2022. PMID: 36334877 Review.
Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis.
Taheriazam A, Abad GGY, Hajimazdarany S, Imani MH, Ziaolhagh S, Zandieh MA, Bayanzadeh SD, Mirzaei S, Hamblin MR, Entezari M, Aref AR, Zarrabi A, Ertas YN, Ren J, Rajabi R, Paskeh MDA, Hashemi M, Hushmandi K. Taheriazam A, et al. Among authors: ertas yn. J Control Release. 2023 Feb;354:503-522. doi: 10.1016/j.jconrel.2023.01.028. Epub 2023 Jan 19. J Control Release. 2023. PMID: 36641122 Review.
Unraveling the function of epithelial-mesenchymal transition (EMT) in colorectal cancer: Metastasis, therapy response, and revisiting molecular pathways.
Sabouni E, Nejad MM, Mojtabavi S, Khoshduz S, Mojtabavi M, Nadafzadeh N, Nikpanjeh N, Mirzaei S, Hashemi M, Aref AR, Khorrami R, Nabavi N, Ertas YN, Salimimoghadam S, Zandieh MA, Rahmanian P, Taheriazam A, Hushmandi K. Sabouni E, et al. Among authors: ertas yn. Biomed Pharmacother. 2023 Apr;160:114395. doi: 10.1016/j.biopha.2023.114395. Epub 2023 Feb 15. Biomed Pharmacother. 2023. PMID: 36804124 Free article. Review.
Gold nanostructure-mediated delivery of anticancer agents: Biomedical applications, reversing drug resistance, and stimuli-responsive nanocarriers.
Entezari M, Yousef Abad GG, Sedghi B, Ettehadi R, Asadi S, Beiranvand R, Haratian N, Karimian SS, Jebali A, Khorrami R, Zandieh MA, Saebfar H, Hushmandi K, Salimimoghadam S, Rashidi M, Taheriazam A, Hashemi M, Ertas YN. Entezari M, et al. Among authors: ertas yn. Environ Res. 2023 May 15;225:115673. doi: 10.1016/j.envres.2023.115673. Epub 2023 Mar 10. Environ Res. 2023. PMID: 36906270 Review.
52 results